AIMOVIG vs QTERNMET XR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. AIMOVIG and QTERNMET XR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	QTERNMET XR
Rating	72/100	New
Pharmacy pays	—	~$341.96 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE AND SAXAGLIPTIN HYDROCHLORIDE
Manufacturer	Amgen Inc	Astrazeneca Ab
Dosage forms	Injectable, Solution	Tablet, extended release
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 6.2 hours (plasma elimination half-life in adults with normal kidney function)

aimovig qternmet xr

Rating

72/100

New

Pharmacy pays

—

~$341.96 /30

Type

Active ingredient

ERENUMAB-AOOE

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE AND SAXAGLIPTIN HYDROCHLORIDE

Manufacturer

Amgen Inc

Astrazeneca Ab

Dosage forms

Injectable, Solution

Tablet, extended release

Drug class

—

Boxed warning

None

Half-life

—

about 6.2 hours (plasma elimination half-life in adults with normal kidney function)

Frequently asked questions

What is the difference between Aimovig and Qternmet XR?

Aimovig contains Erenumab-Aooe, while Qternmet XR contains Dapagliflozin and Metformin Hydrochloride and Saxagliptin Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.